Epigenetic perspectives of COVID-19: Virus infection to disease progression and therapeutic control-Reference-Cited by-同舟云学术

Epigenetic perspectives of COVID-19: Virus infection to disease progression and therapeutic control

Published:2022-12 Issue:12 Volume:1868 Page:166527
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Patra Samir Kumar,Szyf Moshe

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference231 articles.

1. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding;Lu;Lancet,2020

2. Phylogenetic network analysis of SARS-CoV-2 genomes;Forster;Proc. Natl. Acad. Sci. U. S. A.,2020

3. The architecture of SARS-CoV-2 transcriptome;Kim;Cell,2020

4. (2020) a trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19;Cao;N. Engl. J. Med.,2020

5. Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: protocol for restricted public health emergency use;Bhatnagar;Indian J. Med. Res.,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developmental Impacts of Epigenetics and Metabolism in COVID-19;Journal of Developmental Biology;2024-02-09

2. SARS-CoV-2 variants, its recombinants and epigenomic exploitation of host defenses;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2023-12

3. Epigenetic signaling and crosstalk in regulation of gene expression and disease progression;Epigenomics;2023-07

4. Involvement of epigenetics in affecting host immunity during SARS-CoV-2 infection;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2023-03